Impact of apolipoprotein E genotypes on vitamin E and memantine treatment outcomes in Alzheimer's disease

INTRODUCTION: Because apolipoprotein E (APOE) genotypes are known risk factors for Alzheimer's disease (AD), they have been measured in clinical trial participants to determine their effect on treatment outcome. METHODS: We determined APOE genotypes in a subset of subjects (N = 415) who partici...

Descripción completa

Detalles Bibliográficos
Autores principales: Belitskaya-Lévy, Ilana, Dysken, Maurice, Guarino, Peter, Sano, Mary, Asthana, Sanjay, Vertrees, Julia E., Pallaki, Muralidhar, Llorente, Maria, Love, Susan, Schellenberg, Gerard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118101/
https://www.ncbi.nlm.nih.gov/pubmed/30175228
http://dx.doi.org/10.1016/j.trci.2018.06.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118101/
https://www.ncbi.nlm.nih.gov/pubmed/30175228
http://dx.doi.org/10.1016/j.trci.2018.06.001

Ejemplares similares